The Tufts Center for the Study of Drug Development (Tufts CSDD) is an independent, academic, non-profit research center at Tufts University School of Medicine in Boston, Massachusetts. Our mission is to provide data-driven analysis and strategic insight to help drug developers, regulators, and policy makers improve the efficiency and productivity of pharmaceutical R&D.
Established in 1976, Tufts CSDD conducts scholarly analyses addressing the economic, scientific, political, and legal factors that affect the development and regulation of human therapeutics. For over four decades, Tufts CSDD has been a prominent and influential voice in national and international debates on issues pertaining to biomedical innovation and the development of drugs and biologics.
Monitor and report on the development, regulation, and utilization of new drugs and biopharmaceuticals.
Explore the economic, legal, scientific, and political issues affecting pharmaceutical and biopharmaceutical innovation worldwide.
Serve as an information resource on the development and regulation of new therapeutic agents.
Sponsor professional development courses, public forums, and symposia that bring together the perspectives of government, industry, academia, and the public health community.
Raise the level of national and international debate on issues related to new drug and biopharmaceutical product development and regulation.